A case study in the treatment of dementia with Lewy bodies

Objective: To describe the assessment and treatment of an elderly woman with parkinsonism, progressive memory and cognitive deficits, and visual hallucinations. Method:  The patient presented with a 10‐year history of hand tremors, an 8‐year history of short‐term memory problems, and a 3–4‐year hist...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta psychiatrica Scandinavica 2004-07, Vol.110 (1), p.73-75
1. Verfasser: Kaufer, Daniel I.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 75
container_issue 1
container_start_page 73
container_title Acta psychiatrica Scandinavica
container_volume 110
creator Kaufer, Daniel I.
description Objective: To describe the assessment and treatment of an elderly woman with parkinsonism, progressive memory and cognitive deficits, and visual hallucinations. Method:  The patient presented with a 10‐year history of hand tremors, an 8‐year history of short‐term memory problems, and a 3–4‐year history of visual hallucinations. Treatment with donepezil and rivastigmine (successively) did not produce the desired benefits. Then she was started on galantamine 4 mg b.i.d. (escalated to 8 mg b.i.d.). Results:  The patient's social interaction improved and cognitive decline appeared to be stabilized; hallucinations and agitation were also better controlled. Conclusion:  By current criteria, this subject would be labeled as having Parkinson's disease with dementia, although she exhibited the core features of dementia with Lewy body disease. As suggested in previous studies, cholinesterase inhibitors may be effective in treating psychotic symptoms; however, all currently available agents may not be equally effective.
doi_str_mv 10.1111/j.1600-0447.2004.00323.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71993370</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71993370</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3653-b82848857c253fdcbdf0c7b32d0faaa8c3c219141a5d25d22b1f93704165596c3</originalsourceid><addsrcrecordid>eNqNkN9LwzAQx4Mobk7_BcmTb62XpGlTwYcx_AUDBRV8C2mSso521SZl639v6oa-ehzcHff93sEHIUwgJiGu1zFJASJIkiymAEkMwCiLd0do-rs4RlMAIFGaw8cEnTm3DiMnIE7RhHAiIBNsim7mWCtnsfO9GXC1wX5lse-s8o3deNyW2NixqxTeVn6Fl3Y74KI1lXXn6KRUtbMXhzpD7_d3b4vHaPn88LSYLyPNUs6iQlCRCMEzTTkrjS5MCTorGDVQKqWEZpqSnCREcUND0oKUOcsgISnnearZDF3t73527VdvnZdN5bSta7Wxbe9kRvKcBUMQir1Qd61znS3lZ1c1qhskATlyk2s54pEjHjlykz_c5C5YLw8_-qKx5s94ABUEt3vBtqrt8O_Dcr54eQ0d-wYFx3n5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71993370</pqid></control><display><type>article</type><title>A case study in the treatment of dementia with Lewy bodies</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Kaufer, Daniel I.</creator><creatorcontrib>Kaufer, Daniel I.</creatorcontrib><description>Objective: To describe the assessment and treatment of an elderly woman with parkinsonism, progressive memory and cognitive deficits, and visual hallucinations. Method:  The patient presented with a 10‐year history of hand tremors, an 8‐year history of short‐term memory problems, and a 3–4‐year history of visual hallucinations. Treatment with donepezil and rivastigmine (successively) did not produce the desired benefits. Then she was started on galantamine 4 mg b.i.d. (escalated to 8 mg b.i.d.). Results:  The patient's social interaction improved and cognitive decline appeared to be stabilized; hallucinations and agitation were also better controlled. Conclusion:  By current criteria, this subject would be labeled as having Parkinson's disease with dementia, although she exhibited the core features of dementia with Lewy body disease. As suggested in previous studies, cholinesterase inhibitors may be effective in treating psychotic symptoms; however, all currently available agents may not be equally effective.</description><identifier>ISSN: 0001-690X</identifier><identifier>EISSN: 1600-0447</identifier><identifier>DOI: 10.1111/j.1600-0447.2004.00323.x</identifier><identifier>PMID: 15180783</identifier><language>eng</language><publisher>Oxford, UK: Munksgaard International Publishers</publisher><subject>Aged ; Aged, 80 and over ; Carbamates - therapeutic use ; cholinesterase inhibitors ; Cognition Disorders - drug therapy ; Cognition Disorders - etiology ; Drug Resistance ; Female ; galantamine ; Galantamine - therapeutic use ; Hallucinations - drug therapy ; Hallucinations - etiology ; Humans ; Indans - therapeutic use ; Lewy body disease ; Lewy Body Disease - complications ; Lewy Body Disease - drug therapy ; Lewy Body Disease - psychology ; Neuroprotective Agents - therapeutic use ; Nootropic Agents - therapeutic use ; parkinsonian disorders ; Phenylcarbamates ; Piperidines - therapeutic use ; Psychomotor Agitation ; Rivastigmine ; Social Behavior</subject><ispartof>Acta psychiatrica Scandinavica, 2004-07, Vol.110 (1), p.73-75</ispartof><rights>Copyright Blackwell Munksgaard 2004.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3653-b82848857c253fdcbdf0c7b32d0faaa8c3c219141a5d25d22b1f93704165596c3</citedby><cites>FETCH-LOGICAL-c3653-b82848857c253fdcbdf0c7b32d0faaa8c3c219141a5d25d22b1f93704165596c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1600-0447.2004.00323.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1600-0447.2004.00323.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15180783$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kaufer, Daniel I.</creatorcontrib><title>A case study in the treatment of dementia with Lewy bodies</title><title>Acta psychiatrica Scandinavica</title><addtitle>Acta Psychiatr Scand</addtitle><description>Objective: To describe the assessment and treatment of an elderly woman with parkinsonism, progressive memory and cognitive deficits, and visual hallucinations. Method:  The patient presented with a 10‐year history of hand tremors, an 8‐year history of short‐term memory problems, and a 3–4‐year history of visual hallucinations. Treatment with donepezil and rivastigmine (successively) did not produce the desired benefits. Then she was started on galantamine 4 mg b.i.d. (escalated to 8 mg b.i.d.). Results:  The patient's social interaction improved and cognitive decline appeared to be stabilized; hallucinations and agitation were also better controlled. Conclusion:  By current criteria, this subject would be labeled as having Parkinson's disease with dementia, although she exhibited the core features of dementia with Lewy body disease. As suggested in previous studies, cholinesterase inhibitors may be effective in treating psychotic symptoms; however, all currently available agents may not be equally effective.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Carbamates - therapeutic use</subject><subject>cholinesterase inhibitors</subject><subject>Cognition Disorders - drug therapy</subject><subject>Cognition Disorders - etiology</subject><subject>Drug Resistance</subject><subject>Female</subject><subject>galantamine</subject><subject>Galantamine - therapeutic use</subject><subject>Hallucinations - drug therapy</subject><subject>Hallucinations - etiology</subject><subject>Humans</subject><subject>Indans - therapeutic use</subject><subject>Lewy body disease</subject><subject>Lewy Body Disease - complications</subject><subject>Lewy Body Disease - drug therapy</subject><subject>Lewy Body Disease - psychology</subject><subject>Neuroprotective Agents - therapeutic use</subject><subject>Nootropic Agents - therapeutic use</subject><subject>parkinsonian disorders</subject><subject>Phenylcarbamates</subject><subject>Piperidines - therapeutic use</subject><subject>Psychomotor Agitation</subject><subject>Rivastigmine</subject><subject>Social Behavior</subject><issn>0001-690X</issn><issn>1600-0447</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkN9LwzAQx4Mobk7_BcmTb62XpGlTwYcx_AUDBRV8C2mSso521SZl639v6oa-ehzcHff93sEHIUwgJiGu1zFJASJIkiymAEkMwCiLd0do-rs4RlMAIFGaw8cEnTm3DiMnIE7RhHAiIBNsim7mWCtnsfO9GXC1wX5lse-s8o3deNyW2NixqxTeVn6Fl3Y74KI1lXXn6KRUtbMXhzpD7_d3b4vHaPn88LSYLyPNUs6iQlCRCMEzTTkrjS5MCTorGDVQKqWEZpqSnCREcUND0oKUOcsgISnnearZDF3t73527VdvnZdN5bSta7Wxbe9kRvKcBUMQir1Qd61znS3lZ1c1qhskATlyk2s54pEjHjlykz_c5C5YLw8_-qKx5s94ABUEt3vBtqrt8O_Dcr54eQ0d-wYFx3n5</recordid><startdate>200407</startdate><enddate>200407</enddate><creator>Kaufer, Daniel I.</creator><general>Munksgaard International Publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200407</creationdate><title>A case study in the treatment of dementia with Lewy bodies</title><author>Kaufer, Daniel I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3653-b82848857c253fdcbdf0c7b32d0faaa8c3c219141a5d25d22b1f93704165596c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Carbamates - therapeutic use</topic><topic>cholinesterase inhibitors</topic><topic>Cognition Disorders - drug therapy</topic><topic>Cognition Disorders - etiology</topic><topic>Drug Resistance</topic><topic>Female</topic><topic>galantamine</topic><topic>Galantamine - therapeutic use</topic><topic>Hallucinations - drug therapy</topic><topic>Hallucinations - etiology</topic><topic>Humans</topic><topic>Indans - therapeutic use</topic><topic>Lewy body disease</topic><topic>Lewy Body Disease - complications</topic><topic>Lewy Body Disease - drug therapy</topic><topic>Lewy Body Disease - psychology</topic><topic>Neuroprotective Agents - therapeutic use</topic><topic>Nootropic Agents - therapeutic use</topic><topic>parkinsonian disorders</topic><topic>Phenylcarbamates</topic><topic>Piperidines - therapeutic use</topic><topic>Psychomotor Agitation</topic><topic>Rivastigmine</topic><topic>Social Behavior</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kaufer, Daniel I.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Acta psychiatrica Scandinavica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kaufer, Daniel I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A case study in the treatment of dementia with Lewy bodies</atitle><jtitle>Acta psychiatrica Scandinavica</jtitle><addtitle>Acta Psychiatr Scand</addtitle><date>2004-07</date><risdate>2004</risdate><volume>110</volume><issue>1</issue><spage>73</spage><epage>75</epage><pages>73-75</pages><issn>0001-690X</issn><eissn>1600-0447</eissn><abstract>Objective: To describe the assessment and treatment of an elderly woman with parkinsonism, progressive memory and cognitive deficits, and visual hallucinations. Method:  The patient presented with a 10‐year history of hand tremors, an 8‐year history of short‐term memory problems, and a 3–4‐year history of visual hallucinations. Treatment with donepezil and rivastigmine (successively) did not produce the desired benefits. Then she was started on galantamine 4 mg b.i.d. (escalated to 8 mg b.i.d.). Results:  The patient's social interaction improved and cognitive decline appeared to be stabilized; hallucinations and agitation were also better controlled. Conclusion:  By current criteria, this subject would be labeled as having Parkinson's disease with dementia, although she exhibited the core features of dementia with Lewy body disease. As suggested in previous studies, cholinesterase inhibitors may be effective in treating psychotic symptoms; however, all currently available agents may not be equally effective.</abstract><cop>Oxford, UK</cop><pub>Munksgaard International Publishers</pub><pmid>15180783</pmid><doi>10.1111/j.1600-0447.2004.00323.x</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0001-690X
ispartof Acta psychiatrica Scandinavica, 2004-07, Vol.110 (1), p.73-75
issn 0001-690X
1600-0447
language eng
recordid cdi_proquest_miscellaneous_71993370
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Aged
Aged, 80 and over
Carbamates - therapeutic use
cholinesterase inhibitors
Cognition Disorders - drug therapy
Cognition Disorders - etiology
Drug Resistance
Female
galantamine
Galantamine - therapeutic use
Hallucinations - drug therapy
Hallucinations - etiology
Humans
Indans - therapeutic use
Lewy body disease
Lewy Body Disease - complications
Lewy Body Disease - drug therapy
Lewy Body Disease - psychology
Neuroprotective Agents - therapeutic use
Nootropic Agents - therapeutic use
parkinsonian disorders
Phenylcarbamates
Piperidines - therapeutic use
Psychomotor Agitation
Rivastigmine
Social Behavior
title A case study in the treatment of dementia with Lewy bodies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T20%3A38%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20case%20study%20in%20the%20treatment%20of%20dementia%20with%20Lewy%20bodies&rft.jtitle=Acta%20psychiatrica%20Scandinavica&rft.au=Kaufer,%20Daniel%20I.&rft.date=2004-07&rft.volume=110&rft.issue=1&rft.spage=73&rft.epage=75&rft.pages=73-75&rft.issn=0001-690X&rft.eissn=1600-0447&rft_id=info:doi/10.1111/j.1600-0447.2004.00323.x&rft_dat=%3Cproquest_cross%3E71993370%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71993370&rft_id=info:pmid/15180783&rfr_iscdi=true